[pending] ARTIFICIAL TEARS (ARTIFICIAL TEARS)
Pending LLM rewrite. Source: FDA_DRUG D-0404-2025.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Pending LLM scoring against the rubric.
Plain-English summary
cGMP deviations and lack of assurance of sterility.
The recalled product
- Product
- ARTIFICIAL TEARS (ARTIFICIAL TEARS)
- Brand
- ARTIFICIAL TEARS
- Manufacturer
- BRS Analytical Services, LLC
- Category
- Drug — Drugs
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot
- expiry: Lot 126
- exp 10/26/25
- Lot 127
- exp 10/30/25
- Lot 128
- exp 11/02/25
- Lot 129
- exp 11/06/25
- Lot 162
- exp 5/09/26
- Lot 163
- exp 5/14/26
- Lot 164
- exp 5/20/26
- Lot 165
- exp 5/23/26
- Lot 166
- exp 5/29/26
- Lot 167
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27